H Lundbeck A/S (0ND5)

159.85
-0.80(-0.50%)
  • Volume:
    42,395
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    159.85 - 159.85

0ND5 Overview

Prev. Close
160.65
Day's Range
159.85-159.85
Revenue
-
Open
162.5
52 wk Range
150.7-260.2
EPS
-
Volume
42,395
Market Cap
31.51B
Dividend (Yield)
2.50
(1.08%)
Average Vol. (3m)
35,038
P/E Ratio
19.15
Beta
-
1-Year Change
-28.93%
Shares Outstanding
198,698,326
Next Earnings Date
Feb 09, 2022
What is your sentiment on H Lundbeck A/S?
or
Market is currently closed. Voting is open during market hours.

H Lundbeck A/S Company Profile

Employees
5588
Market
Denmark

H Lundbeck A/S is a Denmark-based company active in the pharmaceuticals industry. It is engaged in the research, development, manufacture and marketing of pharmaceuticals for the treatment of brain disorders, such as Alzheimer’s disease, Bipolar disorder, depression, epilepsy, Huntington’s disease, Parkinson’s disease and schizophrenia. Its product portfolio includes: Cipralex for the treatment of depression and anxiety disorders, Ebixa for the treatment of Alzheimer’s disease, Azilect for the treatment of Parkinson’s disease, Xenazine for the treatment of Huntington’s disease and Sabril for the treatment of epilepsy, among others. The Company operates through a number of subsidiaries, such as Lundbeck SAS, Lundbeck GmbH, SIA Lundbeck Latvia and Lundbeck LLC.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyNeutralSellStrong SellStrong Sell
Technical IndicatorsBuyNeutralStrong SellStrong SellStrong Sell
SummaryBuyNeutralStrong SellStrong SellStrong Sell
  • got something of this pharma in my portfolio...lon g term investment. Specyfical sector (neuroligal, brain, mood) very strategic in my opinion.
    0
    • JPMorgan 250 kr 12/5-21
      0
      • Åi6
        0
        Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
        Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.